Monopar Therapeutics (MNPR)
Develops ALXN1840 for Wilson disease and MNPR-101 radiopharmaceuticals for oncology.
$95.03
vs last close−0.69 (−0.72%)
Something off on this page? Send us feedback.
Next report
Nov 12, 26
estimated · in 51 days
EPS estimate
−$0.86
Revenue estimate
—
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$2.23−$0.38−$0.35−$0.48−$0.61−$0.46−$0.62Pending
Estimate−$0.36−$0.65−$0.47−$0.46−$0.51−$1.06−$0.64−$0.86
Surprise−519.4%+41.5%+25.5%−4.3%−19.1%+56.6%+3.6%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported———————Pending
Estimate————————
Surprise————————
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | −$2.04 | — | — |
| Sep 2027 | −$1.00 | — | — |
| Jun 2027 | −$1.28 | — | — |
| Mar 2027 | −$1.30 | — | — |
| Dec 2026 | −$1.04 | — | — |
| Nov 2026 | −$0.86 | — | — |
| Aug 2026 | −$0.64 | −$0.62 | +3.6% |
| May 2026 | −$1.06 | −$0.46 | +56.6% |
| Mar 2026 | −$0.51 | −$0.61 | −19.1% |
| Nov 2025 | −$0.46 | −$0.48 | −4.3% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Dec 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Sep 2017 | |||
| Jun 2017 | |||
| Mar 2017 | |||
| Dec 2016 | |||
| Sep 2016 | |||
| Jun 2016 | |||
| Mar 2016 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | −$2.04 | — | — | $8.2M | — | — | — |
| Sep 2027 | −$1.00 | — | — | $3.8M | — | — | — |
| Jun 2027 | −$1.28 | — | — | $1.0M | — | — | — |
| Mar 2027 | −$1.30 | — | — | $250.0K | — | — | — |
| Dec 2026 | −$1.04 | — | — | $550.0K | — | — | — |
| Nov 12, 2026 | −$0.86 | — | — | $0 | — | — | — |
| Aug 12, 2026 | −$0.64 | −$0.62 | +3.6% | — | — | — | +0.4% |
| May 14, 2026 | −$1.06 | −$0.46 | +56.6% | — | — | — | −0.7% |
| Mar 27, 2026 | −$0.51 | −$0.61 | −19.1% | — | — | — | −0.8% |
| Nov 13, 2025 | −$0.46 | −$0.48 | −4.3% | — | — | — | +5.4% |
| Aug 12, 2025 | |||||||
| May 13, 2025 | |||||||
| Mar 31, 2025 | |||||||
| Nov 8, 2024 | |||||||
| Aug 9, 2024 | |||||||
| May 9, 2024 | |||||||
| Mar 28, 2024 | |||||||
| Nov 9, 2023 | |||||||
| Aug 10, 2023 | |||||||
| May 11, 2023 | |||||||
| Mar 23, 2023 | |||||||
| Nov 10, 2022 | |||||||
| Aug 11, 2022 | |||||||
| May 12, 2022 | |||||||
| Mar 24, 2022 | |||||||
| Nov 12, 2021 | |||||||
| Aug 12, 2021 | |||||||
| May 13, 2021 | |||||||
| Mar 25, 2021 | |||||||
| Nov 12, 2020 | |||||||
| Aug 6, 2020 | |||||||
| May 7, 2020 | |||||||
| Mar 27, 2020 | |||||||
| Dec 23, 2019 | |||||||
| Aug 8, 2019 | |||||||
| May 10, 2019 | |||||||
| Feb 26, 2019 | |||||||
| Nov 9, 2018 | |||||||
| Aug 9, 2018 | |||||||
| May 11, 2018 | |||||||
| Mar 26, 2018 | |||||||
| Sep 30, 2017 | |||||||
| Jun 30, 2017 | |||||||
| Mar 31, 2017 | |||||||
| Dec 31, 2016 | |||||||
| Sep 30, 2016 | |||||||
| Jun 30, 2016 | |||||||
| Mar 31, 2016 |